In AML, DTHIB inhibited the expression of HSP90 and reduced mitochondrial oxidative phosphorylation by downregulating SDHC, a key enzyme complex in the tricarboxylic acid cycle [53]. The gene discussed is SDHC; the disease is acute myeloid leukemia.